Table 2 TTE results: elevated RVSP group versus normal RVSP group
Elevated RVSP n = 42 | Normal RVSP n = 56 | P value | |
|---|---|---|---|
Left ventricular pathology | |||
Left ventricular dysfunction (EF ≤ 40%), no. (%) | 3 (7%) | 5 (9%) | 0.721 |
Left ventricular hypertrophy, no. (%) | 4 (9%) | 4 (7%) | 0.717 |
Diastolic dysfunction, no. (%) | 3 (7%) | 5 (9%) | 0.721 |
Right ventricular pathology | |||
Right ventricle function reduced, no. (%) | 1 (2%) | 2 (4%) | 0.576 |
Tricuspid Annular Plane Systolic Excursion, cm (median, IQR) | 2 (2,2) | 2 (2,3) | 0.401 |
Right ventricular dilation, no. (%) | 7 (17%) | 1 (2%) | 0.008 |
Valvular pathology | |||
Moderate to severe left sided valvular pathology (Mitral or aortic valve disease), no. (%) | 5 (12%) | 5 (9%) | 0.630 |
Moderate to severe tricuspid regurgitation, no. (%) Tricuspid regurgitation, no. (%) | 13 (30%) | 2 (4%) | < 0.001 |
Multiple valvular pathologies, no. (%) | 4 (9%) | 1 (2%) | 0.117 |
Echogenic parameters associated with Pulmonary Hypertension | |||
RVSP mmHg (mean, standard deviation) | 47 ± 10 | 25 ± 6 | < 0.0001 |
IVC dilated, no. (%) | 3 (7%) | 1 (2%) | 0.221 |